| http://www.w3.org/ns/prov#value | - JUPITER, Fla., May 15, 2014 /PRNewswire/ -- Dyadic International, Inc. (Dyadic) (OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical, food and feed industries, announced that Dyadic's Chief Executive Officer Mark Emalfarb will present at B. Riley & Co. 15th
|
